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Background
Sickle cell anemia neurologic complications
The collaboration aims at exploring the relationship between the cerebral vasculature and neurologic
complications in Tanzanian children with sickle cell anemia (SCA). Cerebral vasculopathy in internal
carotid, middle, anterior cerebral, and posterior cerebral arteries is diagnosed by transcranial Doppler
(TCD) utrasonography1 and magnetic resonance angiography (MRA). The neurologic complications
include clinical stroke (ischemic and hemorrhagic) and silent brain infarction (SCI).2,3 Although clinical
stroke (overt cerebral infarction) is a catastrophic complication in SCA, it is relatively rare. However SCI,
diagnosed by magnetic resonance imaging (MRI), is a very common neurologic injury in these patients,
with approximately 50% affected by middle age in the United States. SCI is an independent predictor of
stroke and is associated with neurocognitive impairment.4
Three-quarters of the SCA disease burden is in Africa, and Tanzania is ranked fourth globally.5 We have
been screening for stroke risk using TCD ultrasonography at Muhimbili hospital since 2004. In a study of
200 patients undergoing TCD ultrasonography, of whom 60 with TCD abnormalities had MRI scans, the
prevalence of stroke was 11.5% and the presence of SCI was 37% (verbal communication). However,
the prevalence of SCI and other brain abnormalities6-8 in unselected African patients with SCA is
unknown.
Despite the high prevalence of SCA with neurologic complications, there is a lack of expertise in early
detection and diagnosis using neuroimaging. We have therefore investigated the use of MRI as well as
TCD ultrasonography.
Collaboration and capacity building
Collaboration between Muhimbili University of Health and Allied Sciences (MUHAS) and University
College London (UCL) on SCA research has been ongoing since 2004. We have focussed on the
following:
c Neurologic complications
c MRI and MRA of the brain at 1.5T
c Advanced neuroimaging, including diffusion tensor imaging for white matter disease and gradient-
echo and susceptibility-weighted imaging for brain iron
Experts from UCL have been working with medical personnel and scientists in Tanzania to reduce
morbidity and mortality as a result of neurologic complications by training Tanzanians to perform the
following tasks:
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c Record neurologic history and perform thorough examination.
c Use TCD ultrasonography to detect risk of stroke (Fenella
Kirkham; United Kingdom) (Figure 1).
c Interpret conventional brain MRI scans and magnetic resonance
angiography (MRA) images in SCD (Dawn Saunders, United
Kingdom/United States [Figure 2C]) (Figures 3 and 4).
c Advanced neuroimaging sequences were installed in 2011
into the Muhimbili National Hospital MRI machine (Angela
Darekar, India/United Kingdom; Christopher Clark, United
Kingdom [Figure 2A]).
c Analyze diffusion imaging data (Jamie Kawadler, United
States/United Kingdom [Figure 2D]; Winok Lapidaire, The
Netherlands/United Kingdom [Figure 2B]; and Christopher
Clark, United Kingdom [Figure 2A]).
c Perform neurocognitive testing (Hanne Stotesbury, Norway/
United Kingdom; Melanie Koelbel, Germany/United Kingdom;
Jamie Kawadler, Winok Lapidaire, and Fenella Kirkham, United
Kingdom).
c Train health care providers on brain volume measurement
techniques (Jamie Kawadler, Winok Lapidaire, and Christopher
Clark, United Kingdom).
c Train health care providers on brain iron analysis techniques
(Russell Murdoch and Karin Shmueli, United Kingdom) (Figure 5).
Capacity building
Interpretation of brain abnormalities. The presence of
SCI or stenosis in patients with SCA was identified using MRI
techniques on a Philips 1.5 Tesla scanner, including T2-weighted
(T2W) MRI, fluid attenuated inversion recovery (FLAIR), and MRA.
Figure 2. (A-E) Photos of neuroimaging capacity team during MUHAS-Tanzania and UK-UCL visits.
Figure 3. MRI (A) FLAIR (axial) and (B) T2W
(coronal). Brain images from a 15-year-old female
with SCA without neurologic complications according
to history from parents and child. SCI seen in
2 planes measuring .3 mm in right frontal lobe deep
white matter. (C) MRA: right and left cavernous
ICA stenosis.
Figure 1. (A) TCD training by Fenella Kirkham, MD.
(B) Healthy African children on their way to the
clinic.
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Representative images are shown in Figures 2 and 3 for 2 sample
patients.
Measurement of brain iron. In the deep iron-rich regions of
the brain, magnetic susceptibility values are proportional to tissue
iron content.7 Susceptibility mapping can be used to noninvasively
measure tissue iron concentration.
MUHAS-Tanzania and UCL visits for neuroimaging.
c Mboka Jacob (Tanzania) visited UCL for 5 weeks beginning
in January 2017 and 3 weeks in July 2018. She now has a
Commonwealth scholarship to complete 1 year of study at
UCL.
c Jamie Kawadler, Dawn Saunders, Winok Lapidaire, and
Christopher Clark (United Kingdom) and Angela Darekar
(India and United Kingdom) have visited Tanzania.
c Fenella Kirkham (United Kingdom) has visited Tanzania many
times.
Conclusions
Neuroimaging capacity building in Africa may reduce morbidity and
mortality that results from neurologic complications in SCA. Along
with other Tanzanian scientists, we will be able to explore the effects of
genetic and environmental exposures, including anemia and nutrition.
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Figure 4. (A) MRI: T2W (axial) and (B) MRA. Brain
images from a 7-year-old quadriplegic boy showing
(A) global cerebral infarction and (B) occlusion of
both terminal internal carotid arteries and small
left posterior cerebral artery but no moyamoya
collaterals.
Figure 5. (A) Susceptibility mapping on MRI for
brain iron measurement, (B) brain iron measurements
techniques team, and (C) an imaging machine and
the head of the MUHAS Radiology Department.
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